Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Eng

Showing results (331-340 of 385) with videos related to

Pageof 39
Sort By:
Pharmacotherapy|March 20, 2023
Caring for two in the ICU: Pharmacotherapy in the critically ill pregnant patientMojdeh S Heavner, Grace Erdman, Brooke Barlow, et al.
Journal of Medical Genetics|June 3, 2004
Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypesM A Aldred, R O C Sanford, N S Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2018
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Pharmacotherapy|June 16, 2023
Caring for two in the ICU: Pharmacologic management of pregnancy-related complicationsMojdeh S Heavner, Michaelia D Cucci, Brooke Barlow, et al.
Journal of Medical Genetics|December 7, 2007
Molecular characterisation of a common SDHB deletion in paraganglioma patientsA Cascón, I Landa, E López-Jiménez, et al.
Journal of Medical Genetics|September 10, 2003
Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinomaC M Drovdlic, K A B Goddard, A Chak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
Genes & Development|August 30, 2012
Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and numberVijay G Sankaran, Leif S Ludwig, Ewa Sicinska, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à CalcitonineI Schuffenecker, M Virally-Monod, R Brohet, et al.
Pageof 39

Showing results (331-340 of 385) with videos related to

Sort By:
Pageof 39
Pharmacotherapy|March 20, 2023
Caring for two in the ICU: Pharmacotherapy in the critically ill pregnant patientMojdeh S Heavner, Grace Erdman, Brooke Barlow, et al.
Journal of Medical Genetics|June 3, 2004
Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypesM A Aldred, R O C Sanford, N S Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2018
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Pharmacotherapy|June 16, 2023
Caring for two in the ICU: Pharmacologic management of pregnancy-related complicationsMojdeh S Heavner, Michaelia D Cucci, Brooke Barlow, et al.
Journal of Medical Genetics|December 7, 2007
Molecular characterisation of a common SDHB deletion in paraganglioma patientsA Cascón, I Landa, E López-Jiménez, et al.
Journal of Medical Genetics|September 10, 2003
Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinomaC M Drovdlic, K A B Goddard, A Chak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
Genes & Development|August 30, 2012
Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and numberVijay G Sankaran, Leif S Ludwig, Ewa Sicinska, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à CalcitonineI Schuffenecker, M Virally-Monod, R Brohet, et al.
Pageof 39